|
CALCOCO2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.359700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11319999999793E-05 |
| Normal-vs-Stage2 |
5.662000E-01 |
| Normal-vs-Stage3 |
9.475600E-01 |
| Normal-vs-Stage4 |
6.759000E-01 |
| Stage1-vs-Stage2 |
7.726000E-02 |
| Stage1-vs-Stage3 |
8.378600E-04 |
| Stage1-vs-Stage4 |
1.040690E-03 |
| Stage2-vs-Stage3 |
5.514800E-01 |
| Stage2-vs-Stage4 |
4.272200E-01 |
| Stage3-vs-Stage4 |
7.557000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.217400E-03 |
| Normal-vs-AfricanAmerican |
2.674400E-01 |
| Normal-vs-Asian |
7.646200E-02 |
| Caucasian-vs-AfricanAmerican |
1.107700E-02 |
| Caucasian-vs-Asian |
7.044300E-02 |
| AfricanAmerican-vs-Asian |
9.940700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.568300E-02 |
| Normal-vs-Female |
8.200600E-03 |
| Male-vs-Female |
2.457400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.045000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.335800E-03 |
| Normal-vs-Age(61-80Yrs) |
8.724300E-02 |
| Normal-vs-Age(81-100Yrs) |
5.000800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.771700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.244380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.699000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.524600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.746200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.608400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.695690E-03 |
| Normal-vs-Grade 2 |
2.38310000000297E-06 |
| Normal-vs-Grade 3 |
5.455800E-01 |
| Normal-vs-Grade 4 |
1.037410E-01 |
| Grade 1-vs-Grade 2 |
6.822300E-02 |
| Grade 1-vs-Grade 3 |
1.118940E-03 |
| Grade 1-vs-Grade 4 |
2.803100E-04 |
| Grade 2-vs-Grade 3 |
1.792700E-04 |
| Grade 2-vs-Grade 4 |
2.49389999995575E-06 |
| Grade 3-vs-Grade 4 |
3.926000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.43329792479108E-13 |
| Normal-vs-ccB subtype |
8.384300E-02 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.614300E-02 |
| Normal-vs-N1 |
6.367200E-01 |
| N0-vs-N1 |
2.324200E-01 |
|
|
